Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/08/2012US20120282325 Liposome of irinotecan or its hydrochloride and preparation method thereof
11/08/2012US20120282323 Dry Liposomal PVP-iodine Compositions
11/08/2012US20120282322 Cochleate compositions directed against expression of proteins
11/08/2012US20120282320 Hemostatic dressing
11/08/2012US20120282319 Lotioned wipe product to reduce adhesion of soils or exudates to the skin
11/08/2012US20120282307 Gastric retained gabapentin dosage form
11/08/2012US20120282303 Percutaneous absorption preparation comprising anti-dementia drug
11/08/2012US20120282299 Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide
11/08/2012US20120282298 Corticosteroids for the treatment of joint pain
11/08/2012US20120282297 Method for treating constipation
11/08/2012US20120282290 Mycobacterial Vaccines
11/08/2012US20120282276 Biomarkers predictive of progression of fibrosis
11/08/2012US20120282267 Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain
11/08/2012US20120282266 Anti-neoplastic uses of artemin antagonists
11/08/2012US20120282261 Deuterated analogs of (4S)-4-Ethyl-4-hydroxy-11-[2- (trimethylsilyl)ethyl]-1H-pyrano[3', 4':6,7] indolizino [1,2-b]quinoline-3,14(4H, 12H)-dione and methods of use thereof
11/08/2012US20120282259 Mutant smoothened and methods of using the same
11/08/2012US20120282258 Crlf2 in precursor b-cell acute lymphoblastic leukemia
11/08/2012US20120282255 Methods and compositions for the treatment of alcoholism and alcohol dependence
11/08/2012US20120282252 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes
11/08/2012US20120282245 Biomarkers and assays for the treatment of cancer
11/08/2012US20120282242 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
11/08/2012US20120282224 Markers associated with ribavirin-induced anemia
11/08/2012US20120282223 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
11/08/2012US20120282222 Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases
11/08/2012US20120282221 Bromo-phenyl substituted thiazolyl dihydropyrimidines
11/08/2012US20120282220 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/08/2012US20120282218 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
11/08/2012US20120282213 Use of Polymeric or Oligomeric Active Ingredients for Medical Articles
11/08/2012US20120282211 Antibodies and conjugates for modulators of angiogenesis
11/08/2012US20120282204 Protection Against Sunburn And Skin Problems With Topical And Orally-Ingested Dosages Of Zeaxanthin
11/08/2012US20120282202 Aqueous composition for topical application, method of preparation, uses and device
11/08/2012US20120282196 Smoothened polypeptides and methods of use
11/08/2012US20120282191 Orally dispersible tablet
11/08/2012US20120282189 Improved Medicinal Aerosol Formulations
11/08/2012US20120282187 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved safety profile over conventional warfarin therapy
11/08/2012US20120282186 Templated nanoconjugates
11/08/2012US20120282180 Compounds with Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof
11/08/2012US20120282179 Methods of Using C-Met Modulators
11/08/2012US20120282177 ROR1 as Therapeutic and Diagnostic Target
11/08/2012US20120282172 Targeted delivery to human diseases and disorders
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012US20120282168 Methods of sensitizing cancer to therapy-induced cytotoxicity
11/08/2012DE102011100832A1 Wirkstoffkombinationen von Hesperidin zur Behandlung von Schlafstörungen Drug combinations of hesperidin treatment for insomnia
11/08/2012DE102011100581A1 Behandlung von hyperproliferativen Erkrankungen des Urogenitaltraktes Treatment of hyperproliferative disorders of the genitourinary tract
11/08/2012DE102011075399A1 New substituted imidazopyrid(az)ine compounds are soluble guanylate cyclase stimulators, useful to treat e.g. heart disease, angina pectoris, hypertension, pulmonary hypertension, ischemia, vascular disease or renal insufficiency
11/08/2012DE102011075398A1 Substituierte Imidazopyridazine und ihre Verwendung Substituted Imidazopyridazine and their use
11/08/2012DE102011075354A1 Dosage form comprises at least one first active substance-containing unit, and at least one second active substance-containing unit, and both units comprise a first active substance
11/08/2012CA2839790A1 Rapid dissolve tablet compositions for vaginal administration
11/08/2012CA2836769A1 Combination pharmaceutical compositions and uses thereof
11/08/2012CA2836768A1 Amorphous solid salts
11/08/2012CA2835069A1 Methods for detecting enhanced risk of opioid-induced hypoxia in a patient
11/08/2012CA2835062A1 Transdermal compositions of ibuprofen and methods of use thereof
11/08/2012CA2835018A1 Pentylenetetrazole derivatives
11/08/2012CA2835015A1 Radiolabeled amino acids for diagnostic imaging
11/08/2012CA2835013A1 Eye drops for treatment of conjunctivochalasis
11/08/2012CA2834999A1 Novel cephalosporins useful as antibacterial agents
11/08/2012CA2834928A1 Compounds for inflammation and immune-related uses
11/08/2012CA2834885A1 Composition and method for treatment of diabetes
11/08/2012CA2834850A1 Methods for treating prostate cancer
11/08/2012CA2834829A1 Rifaximin dimethylformamide solvate
11/08/2012CA2834821A1 Crystalline salts of asenapine
11/08/2012CA2834818A1 Novel solid forms of antibiotics
11/08/2012CA2834788A1 Cochleate compositions and methods of making and using same
11/08/2012CA2834778A1 Method of treating cancer and bone cancer pain
11/08/2012CA2834746A1 Novel compounds and compositions for the inhibition of nampt
11/08/2012CA2834696A1 Csf-1r inhibitors for treatment of brain tumors
11/08/2012CA2834692A1 Pyruvate kinase activators for use in therapy
11/08/2012CA2834602A1 Pyruvate kinase activators for use in therapy
11/08/2012CA2834422A1 Method for utilizing extraction residue of yeast extract
11/08/2012CA2834414A1 Multiple myeloma treatment
11/08/2012CA2834368A1 Use of fk506 for the treatment of pulmonary arterial hypertension
11/08/2012CA2834301A1 Treatment of psoriasis
11/08/2012CA2834237A1 Isoxazolines as therapeutic agents
11/08/2012CA2834173A1 Composition useful for the treatment of lipid metabolism disorders
11/08/2012CA2834043A1 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors
11/08/2012CA2833935A1 Novel compounds as modulators of protein kinases
11/08/2012CA2833887A1 Drug substances, pharmaceutical compositions and methods for preparing the same
11/08/2012CA2833780A1 Prenylated hydroxystilbenes
11/08/2012CA2833509A1 Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]benzo- diazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives
11/08/2012CA2833324A1 A composition for treating autoimmune disorders and methods thereof
11/08/2012CA2832504A1 Compounds for inhibiting cell proliferation in egfr-driven cancers
11/08/2012CA2832390A1 Isoindolinone derivatives
11/08/2012CA2832302A1 Novel benzofurane-piperidine compounds
11/07/2012EP2520654A1 Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
11/07/2012EP2520652A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associates genes
11/07/2012EP2520651A2 Sirna for inhibiting c-met expression and an anti-cancer composition comprising the same
11/07/2012EP2520605A1 Method for producing biocidal polyguanidine, and biocidal polyguanidine
11/07/2012EP2520581A1 Method for the determination the purity of 5-Azacytidine
11/07/2012EP2520580A1 Halogenated dideoxy saccharide derivatives, preparation method and use thereof
11/07/2012EP2520577A1 Pyrazolo[1,5-a]pyrimidine compounds as CB1 receptor antagonists
11/07/2012EP2520575A1 1,3,4-oxadiazole-2-carboxamide compound
11/07/2012EP2520574A1 Amiloride analogues substituted on the cyclic guanidine moiety as ENaC blockers for treating respiratory diseases
11/07/2012EP2520573A1 Compounds with matrix-metalloproteinase inhibitory activity
11/07/2012EP2520570A1 Aminopyridine compound
11/07/2012EP2520568A1 Spirocyclic nitriles as inhibitors of protease
11/07/2012EP2520566A1 New Pharmaceutical Compounds
11/07/2012EP2520562A1 Anti-leishmania compound and anti-leishmania drug
11/07/2012EP2520305A1 Medicinal composition including sunflower extract, preparative method and use thereof
11/07/2012EP2520304A1 Ceramide production enhancer and moisturizing agent
1 ... 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 ... 7860